Jump to:

Mayo Clinic

IARC PLAN

Date: 1993
Length: 2 pages
2501348677-2501348678
Jump To Images
mayo_ets 2501348677-2501348678

Abstract

Outlines plan for assessing and mitigating the impact of the IARC study on ETS exposure and lung cancer in nonsmokers. Asks, "Do we want to have an impact on study findings? Can we? If yes, what opportunities exists formally or informally to enable intervention? Are there pre-publication peer or committee reviews?" States assumption that the study will find some elevated risk in lung cancer among ETS-exposed nonsmokers, and lists plans to use media to address this outcome (spokespeople, scientists, journalists, op-eds). Suggests evaluation of legislative/regulatory impact of the study and "locking in - via legislation or regulation - acceptable solutions to accommodate smoking in public places in lieu of waiting for less desirable alternatives post-IARC." Suggests evaluation of IARC's credibility in scientific community and discrediting other ETS-related studies to potentially minimize impact of IARC report. Includes many handwritten notes.

Fields

Type
Outline
Proposal
Company
Philip Morris
Site
MN Depository
Named Person
M.W.
T.L.
Goodheart, Jan (PM Asia, Worldwide Regulatory Affairs Mgr.)
Jan Goodheart was the Manager for Worldwide Regulatory Affairs for Philip Morris. (PMI's Introduction to Privilege Log and Glossary of Names, Estate of Burl Butler v. PMI, et al, April 19, 1996)
Leiber, Cathy L. (PM Marketing & Brand Management)
Defense
*Harris, Don (use Harris, Donald S.)
1992
Davies, David R. (Philip Morris (Australia) Limited)
Vice President Corporate Affairs - Australia, Philip Morris (Australia) Limited, Australia
Carchman, Richard Allan, Ph.D. (PM Scientific Affairs, Research & Development VP)
Philip Morris Director and worked in Scientific Affairs. Reported to Cathy ellis.
J.L.
C.V.M.
Pages, Robert A. (Philip Morris scientist & researcher, c. 1980s)
Robert A. Pages gave a deposition that was 25 pgs with one exhibit in the Carlisle v. Philip Morris Inc., et al case on 10/30/86 and he gave another deposition that was 207 pgs on 9/23/88 for the Rothgeb v. ATC, et al case. He was a Scientist and he worked for Philip Morris, Inc. and was born on 10/10/41 and is in infirm health. (PMI's Revised Initial Disclosure, June 27, 1996) (PMI's Introduction to Privilege Log and Glossary of Names, Estate of Burl Butler v. PMI, et al, April 19, 1996) Robert Pages, who gave depositions in 1986 and 1988, is apparently in poor health. (Alexandra Wagner, Ness, Motley letter to Grant Kaiser, 1/10/97)
C.L.
T.A.
Parsons, Michael (PMI ETS Spokesperson)
1993
Lyberg, M.
Lindheim, James B. (Executive VP and Dir. of Public Affairs of Burson Marstellar)
James B. Lindheim worked for Burson Marstellar public relations company c. 1989. By 1996, Lindheim had opened his own consulting business, J. Lindheim and Company, and was still consulting for Philip Morris.
H.R.
Named Organization
International Agency for Research on Cancer (IARC) (WHO cancer research arm)
International Agency for Research on Cancer - The cancer research arm of the WHO. Conducted a multi-center epidemiology study on ETS, initiated in 1988, data collection completed in 1994 and results were published in 1998
Shook, Hardy & Bacon (Tobacco Industry law firm)
Tobacco Industry law firm based in Kansas City, KS.
IHA
Eurotoque
*EPA ( use United States Environmental Protection Agency)
Region
Europe
United States
Thesaurus Term
Lung Cancer
Research Studies
Industry Response
Mass Media
Industry Employees
Non-Smokers
ETS Exposure
Public Places
Keyword
HoReCa
IARC Multinational Study on ETS and Lung Cancer

No images found for document.